Oversizing lung allografts deteriorates outcomes in patients with pulmonary fibrosis
View abstract on PubMed
Summary
This summary is machine-generated.Oversizing lung allografts by more than 10% negatively impacts lung transplant outcomes. Undersized grafts showed better early and long-term survival for pulmonary fibrosis patients.
Area Of Science
- Thoracic Surgery
- Transplantation Medicine
- Pulmonary Medicine
Background
- Lung transplantation is the sole curative option for end-stage pulmonary fibrosis.
- Optimal lung allograft sizing remains a critical, debated factor influencing postoperative results.
- This study investigates the impact of donor-recipient predicted total lung capacity ratio (DRPR) on outcomes.
Purpose Of The Study
- To determine the effect of lung allograft size mismatch on postoperative outcomes.
- To compare outcomes between undersized, size-matched, and oversized lung allografts in pulmonary fibrosis patients.
Main Methods
- Retrospective review of 422 lung transplant recipients from January 2010 to May 2023.
- Patients categorized into undersized (DRPR <1.0), size-matched (1.0 ≤ DRPR <1.1), and oversized (DRPR ≥1.1) groups.
- Outcomes analyzed using statistical methods including Kaplan-Meier and multivariable analyses.
Main Results
- Oversized allografts (n=26) were associated with higher rates of PGD grade 3 and in-hospital mortality compared to undersized grafts (n=296).
- Long-term survival was significantly better in the undersized group compared to both oversized and size-matched (n=101) groups.
- A donor-recipient predicted total lung capacity ratio (DRPR) >1.1 indicated adverse outcomes.
Conclusions
- Oversizing lung allografts by over 10% (DRPR ≥1.1) is linked to poorer early postoperative outcomes and reduced long-term survival.
- Undersizing lung allografts may offer superior survival benefits for pulmonary fibrosis patients.
- Careful consideration of allograft size is crucial for optimizing lung transplant success.

